Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine

American Journal of Health-System Pharmacy

Volumn 66, Issue 22, 2009, Pages 2024-2026

  Patel, Priti N ^a   Ezzo, Danielle C ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Antiemetics; Contraceptives, oral; Drug withdrawal; Meclizine; Motion sickness; Nausea; Parasympatholytic agents; Patches transdermal; Scopolamine; Toxicity; Zolmitriptan

Indexed keywords

MECLOZINE; ORAL CONTRACEPTIVE AGENT; SCOPOLAMINE; ZOLMITRIPTAN;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; DRY EYE; FEMALE; HUMAN; MIGRAINE; MOTION SICKNESS; NAUSEA; PRIORITY JOURNAL; RECURRENT DISEASE; STANDING; TRAVEL; TREATMENT DURATION; WALKING; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 70450167489     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080569     Document Type: Article

References (13)

1. Transderm Scop (prescribing information). Parsippany, NJ: Novartis Consumer Health; 2006 Feb.
2. Heller Brown J, Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton L, Lazo J, Parker K, eds. The pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2006:183-200.
3. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245
4. Saxena K, Saxena S. Scopolamine withdrawal syndrome. Postgrad Med. 1990; 87:63-65
5. Feder R. Transdermal scopolamine withdrawal syndrome. Clin Neuropharmacol. 1999; 22:120. Letter.
6. Skidgel R, Erdos E. Histamine, bradykinin, and their antagonists. In: Brunton L, Lazo J, Parker K, eds. The pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2006:629-651
7. DiPiro CV. Nausea and vomiting. In: DiPiro J, Talbert R, Yee G et al., eds. Pharmacotherapy: a pathophysiologic approach. 7th ed. New York: McGraw Hill; 2008:607-616
8. Lexi-Comp Online. Meclizine. http://online.lexi.com/crlonline (accessed 2008 Oct 17).
9. Meclizine hydrochloride. In: McEvoy GK, ed. AHFS drug information 2008. Bethesda, MD: American Society of Health-System Pharmacists; 2008:2992.
10. Meclizine. In: Klasco RK, ed. Drug-Knowledge System (electronic version). Thomson Healthcare, Greenwood Village, CO; 2008.
11. Sutin EL, Shiromani PJ, Kelsoe JR et al. Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci. 1986; 39:2419-2427
12. Thor DH, Holloway WR. Social play in juvenile rats during scopolamine withdrawal. Physiol Behav. 1984; 32:217-220
13. Ranade VV. Drug delivery systems. 6. Transdermal drug delivery. J Clin Pharmacol. 1991; 31:401-418